RxDoctor Payments Data

Alhamza Al-Bayati, MD

Vascular Neurology · Pittsburgh, PANPI 1104121227

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $40,996 of the $66,173 with a category attached, or 62.0%. Medical Device Business Services, Inc. accounts for 84.2% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $34,565, more than ten times the $31 reported in 2020. Among vascular neurology clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$66,173in general payments, 2019–2025

Across 85 payments — averaging $778.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$56K
  • Scientia Vascular$7K
  • Stryker$2K
  • Microvention, Inc.$475
  • Balt USA, LLC$293
  • Viz.ai, Inc.$242
  • plus $659 from 6 others
$67,670in research payments, 2019–2025

Across 8 payments — averaging $8458.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medical Device Business Services, Inc.$66K
  • Imperative Care, Inc$1K

What the payments were for

  • Consulting fees$40,99662%
  • Travel & lodging$22,48734%
  • Food & beverage$2,6904%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$66,173 in reported general payments places this provider in the 90th percentile of 52 vascular neurology providers in Pennsylvania.

See all vascular neurology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$44,705
Medicare patients
74
Services billed
244

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate27$233
Atorvastatin Calcium25$152

Paid to pharmacies, not to this prescriber.

Other vascular neurology in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →